Barclays maintains West Pharmaceutical at Overweight
Barclays kept its Overweight rating on West Pharmaceutical.
Story updates
03:51:35 PM UTC
SquawkNews
West Pharma Price Target Raised to $440.00/Share From $400.00 by Barclays
Barclays kept its Overweight rating on West Pharmaceutical.